CME Group Equity Method Income increased by 16.1% to $102.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.1%, from $88.20M to $102.40M. Over 4 years (FY 2021 to FY 2025), Equity Method Income shows an upward trend with a 10.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase reflects strong performance from joint ventures or strategic partners, while a decrease indicates underperformance in those specific investments.
This metric captures the company's proportionate share of the net earnings or losses from investments in unconsolidated...
Common in technology and manufacturing sectors where joint ventures are used for R&D or supply chain integration.
is_equity_method_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $55.70M | $66.40M | $67.50M | $73.30M | $87.30M | $76.50M | $64.00M | $78.20M | $75.10M | $76.80M | $66.80M | $87.20M | $86.40M | $86.10M | $91.20M | $88.20M | $99.00M | $96.30M | $88.20M | $102.40M |
| QoQ Change | — | +19.2% | +1.7% | +8.6% | +19.1% | -12.4% | -16.3% | +22.2% | -4.0% | +2.3% | -13.0% | +30.5% | -0.9% | -0.3% | +5.9% | -3.3% | +12.2% | -2.7% | -8.4% | +16.1% |
| YoY Change | — | — | — | — | +56.7% | +15.2% | -5.2% | +6.7% | -14.0% | +0.4% | +4.4% | +11.5% | +15.0% | +12.1% | +36.5% | +1.1% | +14.6% | +11.8% | -3.3% | +16.1% |